专家笔谈

新冠疫情下儿童呼吸道感染病毒病原学的变迁及诊断策略

  • 王宇清 ,
  • 蒋吴君 ,
  • 顾文婧
展开
  • 苏州大学附属儿童医院呼吸科(江苏苏州 215000)
王宇清(1976—),医学博士,主任医师,教授,博士生导师。青年编委,ORCID:0000-0002-4153-3984,苏州大学附属儿童医院呼吸科副主任兼五病区主任,江苏省医学青年人才、姑苏卫生重点人才,曾到美国洛杉矶儿童医院访问学习。兼任中华医学会变态反应学分会青年委员会副主任委员,中华医学会儿科学分会青年呼吸学组副组长,中国研究型医院学会过敏专委会儿童过敏学组副组长,江苏省医学会变态反应学分会常务委员,江苏省医学会儿科学分会呼吸学组秘书,苏州市医学会变态反应学分会副主任委员,苏州市医学会睡眠专委会副主任委员等。主要从事儿童呼吸道感染、慢性咳嗽、睡眠呼吸障碍疾病的临床及科研工作。主持国家自然科学基金面上项目、省市级课题多项,获得全国妇幼健康科学技术奖三等奖、教育部科技进步奖二等奖、江苏省科技进步三等奖,发表SCI论著23篇。被评为“中华医学会变态反应学分会第二届十佳杰出青年”。

收稿日期: 2022-02-10

  网络出版日期: 2022-04-07

基金资助

国家自然科学基金面上项目(81573167);苏州市科技创新项目No(SLT201939);苏州市科技创新项目(SKY2021009)

Changes in viral etiology of children with respiratory tract infection and diagnostic strategy during the COVID-19 pandemic

  • Yuqing WANG ,
  • Wujun JIANG ,
  • Wenjing GU
Expand
  • Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215000, Jiangsu, China

Received date: 2022-02-10

  Online published: 2022-04-07

摘要

呼吸道感染是儿童时期最常见的感染性疾病,病毒是主要的病原体。新型冠状病毒肺炎(coronavirus disease 2019,COVID-2019)疫情以来,儿童呼吸道病原的流行特征和病原谱均有所变化,病原学检测及持续监测具有重要意义,可为临床诊断、治疗及防控提供依据。

本文引用格式

王宇清 , 蒋吴君 , 顾文婧 . 新冠疫情下儿童呼吸道感染病毒病原学的变迁及诊断策略[J]. 临床儿科杂志, 2022 , 40(4) : 241 -246 . DOI: 10.12372/jcp.2022.22e0195

Abstract

Respiratory tract infection is the commonest infectious disease in childhood, and virus is the main pathogen. Since the outbreak of coronavirus disease 2019 (COVID-2019), the epidemiological characteristics and spectrum of respiratory tract pathogens in children have changed. Etiological detection and continuous monitoring are of great significance and can provide evidence for clinical diagnosis, treatment and prevention and control.

参考文献

[1] Klavinskis LS, Liu MA, Lu S. A timely update of global COVID-19 vaccine development[J]. Emerg Microbes Infect, 2020, 9(1):2379-2380.
[2] Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals[J]. Lancet, 2016, 388:3027-3035.
[3] Zhong-Jie Li, Hai-Yang Zhang, Li-Li Ren, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1):5026.
[4] Pneumonia Etiology Research for Child Health(PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study[J]. Lancet, 2019, 394(10200):757-779.
[5] Baker RE, Park SW, Yang W, et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections[J]. Proc Natl Acad Sci U S A, 2020, 117:30547-30553.
[6] European Centre for Disease Prevention and Control(ECDC). Influenza virus characterisation, summary Europe, December 2020[EB/OL]. (2022-02-10) https://www.ecdc.europa.eu/sites/default/files/documents/Influenza-characterisation-report-December-2020.pdf.
[7] Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased infuenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020[J]. MMWR Morb Mortal Wkly Rep, 2020, 69:1305-1309.
[8] Minney-Smith C, Smith D, Stocks N, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020[J]. Euro Surveill, 2020, 25(47):2001847.
[9] 中国疾病预防控制中心, 病毒病预防控制所. 中国流感流行情况概要. 2021年1月11日周报[EB/OL]. (2022-02-10) https://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202101/P020210111510404437185.pdf.
[10] Zhang RX, Chen DM, Qian Y, et al. Surges of hospital-based rhinovirus infection during the 2020 coronavirus disease-19 (COVID-19) pandemic in Beijing, China[J]. World J Pediatr, 2021, 17(6):590-596.
[11] 闫芍药, 原伟莉, 黎巧玲. 2016-2020年西安地区急性呼吸道感染患者病毒病原学特征分析[J]. 华南预防医学, 2021, 47(11):1417-1419.
[12] 花盛浩, 邵雪君, 徐俊. 新型冠状病毒肺炎常态化防控下儿童常见呼吸道病毒感染谱的变化[J]. 中华传染病杂志, 2021, 39(10):621-625.
[13] European Centre for Disease Prevention and Control(ECDC). Influenza virus characterisation-Summary Europe, December 2021[EB/OL].(2022-02-10) https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-december-2021.
[14] 中国疾病预防控制中心, 病毒病预防控制所. 中国流感流行情况概要. 12月17日周报[EB/OL]. (2022-02-10) http://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202112/P020211217607106751971.pdf.
[15] Gastaldi A, Donà D, Barbieri E, et al. COVID-19 lesson for respiratory syncytial virus (RSV): hygiene works[J]. Children (Basel), 2021, 8(12):1144.
[16] ECDC. Surveillance atlas of infectious diseases[EB/OL]. (2022-02-10) https://atlas.ecdc.europa.eu/public/index.aspx.
[17] 王莉莉, 刘志, 彭虹艳, 等. 新型冠状病毒肺炎疫情暴发前后儿童呼吸道合胞病毒感染流行特征分析[J]. 实用预防医学, 2021, 28(12):1487-1489.
[18] 黄瑶, 张秀玲, 王艳, 等. 2017-2020年扬州地区住院肺炎患者呼吸道病毒监测结果分析[J]. 检验医学, 2021, 36(11):1135-1139.
[19] Foley DA, Yeoh DK, Minney-Smith CA, et al. The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019-related public health measures[J]. Clin Infect Dis, 2021, 73(9):e2829-e2830.
[20] Agha R, Avner JR. Delayed seasonal RSV surge observed during the COVID-19 pandemic[J]. Pediatrics, 2021, 148(3):e2021052089.
[21] Sullivan SG, Carlson S, Cheng AC, et al. Where has all the infuenza gone? The impact of COVID-19 on the circulation of infuenza and other respiratory viruses, Australia, March to September 2020[J]. Euro Surveill, 2020, 25:2001847.
[22] Takashita E, Kawakami C, Momoki T, et al. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic[J]. Influenza Other Respir Viruses, 2021, 15(4):488-494.
[23] 王宇清, 季伟, 陈正荣, 等. 2006-2009年苏州地区儿童急性呼吸道感染人类偏肺病毒感染的流行特点及与气候因素的相关性研究[J]. 中华儿科杂志, 2011, 49(3):214-217.
[24] Chen Z, Zhu Y, Wang Y, et al. Association of meteorological factors with childhood viral acute respiratory infections in subtropical China: an analysis over 11 years[J]. Arch Virol, 2014, 159(4):631-639.
[25] Wu A, Mihaylova VT, Landry ML, et al. Interference between rhinovirus and infuenza A virus: a clinical data analysis and experimental infection study[J]. Lancet Microbe, 2020, 1:e254-e262.
[26] Casalegno JS, Ottmann M, Duchamp MB, et al. Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France[J]. Clin Microbiol Infect, 2010, 16:326-629.
[27] Achten NB, Wu P, Bont L, et al. Interference between respiratory syncytial virus and human rhinovirus infection in infancy[J]. J Infect Dis, 2017, 215:1102-1106.
[28] Agrawal B. Heterologous immunity: role in natural and vaccineinduced resistance to infections[J]. Front Immunol, 2019, 10:2631.
[29] Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses[J]. Annu Rev Immunol, 2014, 32:513-545.
[30] Price OH, Sullivan SG, Sutterby C, et al. Using routine testing data to understand circulation patterns of influenza A, respiratory syncytial virus and other respiratory viruses in Victoria, Australia[J]. Epidemiol Infect, 2019, 147:e221.
[31] Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China[J]. Emerg Infect Dis, 2020, 26(6):1324-1326.
[32] Jiang W, Wu M, Zhou J, et al. Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia[J]. BMC Infectious Diseases, 2017, 17(1):787.
[33] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(第八版)[EB/OL]. (2022-02-10) http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml.
[34] Thavagnanam S, Christie SN, Doherty GM, et al. Respiratory viral infection in lower airways of asymp-tomatic children[J]. Acta Paediatr, 2010, 99(3):394-398.
[35] Lu AZ, Shi P, Wang LB, et al. Diagnostic value of nasopharyngeal aspirates in children with lower respiratory tract infections[J]. Chin Med J (Engl), 2017, 130(6):647-651.
[36] Tan J, Wu J, Jiang W, et al. Etiology, clinical characteristics and coinfection status of bronchiolitis in Suzhou[J]. BMC Infect Dis, 2021, 21(1):135.
[37] Leung EC, Chow VC, Lee MK, et al. Evaluation of the xpert xpress SARS-CoV-2/Flu/RSV assay for simultaneous detection of SARS-CoV-2, influenza A and B viruses, and respiratory syncytial virus in nasopharyngeal specimens[J]. J Clin Microbiol, 2021, 59(4):e02965-20.
[38] Chung HY, Jian MJ, Chang CK, et al. Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing[J]. Aging (Albany NY), 2021, 13(23):24931-24942.
[39] Yun J, Park JH, Kim N, et al. Evaluation of three multiplex real-time reverse transcription PCR assays for simultaneous detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus in nasopharyngeal swabs[J]. J Korean Med Sci, 2021, 36(48):e328.
[40] Nörz D, Hoffmann A, Aepfelbacher M, et al. Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform[J]. J Med Microbiol, 2021, 70(2):001295.
[41] Nabti LZ, Sahli F, Olowo-Okere A, et al. Molecular characterization of clinical carbapenem-resistant enterobacteriaceae isolates from Sétif, Algeria[J]. Microb Drug Resist, 2021: 274-279.
[42] Marí-Almirall M, Ferrando N, Fernández MJ, et al. Clonal spread and intra- and inter-species plasmid dissemination associated with Klebsiella pneumoniae carbapenemase-producing enterobacterales during a hospital outbreak in Barcelona, Spain[J]. Front Microbiol, 2021, 12:781127.
[43] Khanal M, Joshi PR, Paudel S, et al. Methicillin-resistant coagulase negative staphylococci and their antibiotic susceptibility pattern from healthy dogs and their owners from kathmandu valley[J]. Trop Med Infect Dis, 2021, 6(4):194.
[44] Zhao F, Lu J, Lu B, et al. A novel strategy for the detection of SARS-CoV-2 Variants based on multiplex PCR-Mass spectrometry minisequencing technology[J]. Microbiol Spectr, 2021, 9(3): e0126721.
文章导航

/